253 related articles for article (PubMed ID: 24992731)
1. Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features.
Lei J; Mesters JR; Drosten C; Anemüller S; Ma Q; Hilgenfeld R
Antiviral Res; 2014 Sep; 109():72-82. PubMed ID: 24992731
[TBL] [Abstract][Full Text] [Related]
2. Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin.
Lei J; Hilgenfeld R
Virol Sin; 2016 Aug; 31(4):288-99. PubMed ID: 27245450
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression.
Bailey-Elkin BA; Knaap RC; Johnson GG; Dalebout TJ; Ninaber DK; van Kasteren PB; Bredenbeek PJ; Snijder EJ; Kikkert M; Mark BL
J Biol Chem; 2014 Dec; 289(50):34667-82. PubMed ID: 25320088
[TBL] [Abstract][Full Text] [Related]
4. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
[TBL] [Abstract][Full Text] [Related]
5. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
[TBL] [Abstract][Full Text] [Related]
7. Structurally Guided Removal of DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory Syndrome Coronavirus.
Daczkowski CM; Goodwin OY; Dzimianski JV; Farhat JJ; Pegan SD
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931677
[TBL] [Abstract][Full Text] [Related]
8. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease.
Chou CY; Lai HY; Chen HY; Cheng SC; Cheng KW; Chou YW
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):572-81. PubMed ID: 24531491
[TBL] [Abstract][Full Text] [Related]
11. Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.
Needle D; Lountos GT; Waugh DS
Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1102-11. PubMed ID: 25945576
[TBL] [Abstract][Full Text] [Related]
12. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors.
Henderson JA; Verma N; Harris RC; Liu R; Shen J
J Chem Phys; 2020 Sep; 153(11):115101. PubMed ID: 32962355
[TBL] [Abstract][Full Text] [Related]
13. Papain-like protease 1 from transmissible gastroenteritis virus: crystal structure and enzymatic activity toward viral and cellular substrates.
Wojdyla JA; Manolaridis I; van Kasteren PB; Kikkert M; Snijder EJ; Gorbalenya AE; Tucker PA
J Virol; 2010 Oct; 84(19):10063-73. PubMed ID: 20668092
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes.
Lin MH; Moses DC; Hsieh CH; Cheng SC; Chen YH; Sun CY; Chou CY
Antiviral Res; 2018 Feb; 150():155-163. PubMed ID: 29289665
[TBL] [Abstract][Full Text] [Related]
15. Critical Assessment of the Important Residues Involved in the Dimerization and Catalysis of MERS Coronavirus Main Protease.
Ho BL; Cheng SC; Shi L; Wang TY; Ho KI; Chou CY
PLoS One; 2015; 10(12):e0144865. PubMed ID: 26658006
[TBL] [Abstract][Full Text] [Related]
16. Synonymous and Biased Codon Usage by MERS CoV Papain-Like and 3CL-Proteases.
Kandeel M; Altaher A
Biol Pharm Bull; 2017 Jul; 40(7):1086-1091. PubMed ID: 28420819
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus.
Cheng KW; Cheng SC; Chen WY; Lin MH; Chuang SJ; Cheng IH; Sun CY; Chou CY
Antiviral Res; 2015 Mar; 115():9-16. PubMed ID: 25542975
[TBL] [Abstract][Full Text] [Related]
18. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities.
Mielech AM; Kilianski A; Baez-Santos YM; Mesecar AD; Baker SC
Virology; 2014 Feb; 450-451():64-70. PubMed ID: 24503068
[TBL] [Abstract][Full Text] [Related]
19. X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design.
Clasman JR; Báez-Santos YM; Mettelman RC; O'Brien A; Baker SC; Mesecar AD
Sci Rep; 2017 Jan; 7():40292. PubMed ID: 28079137
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.
Zhang W; Bailey-Elkin BA; Knaap RCM; Khare B; Dalebout TJ; Johnson GG; van Kasteren PB; McLeish NJ; Gu J; He W; Kikkert M; Mark BL; Sidhu SS
PLoS Pathog; 2017 May; 13(5):e1006372. PubMed ID: 28542609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
